GORE CARDIOFORM Approved by FDA to Treat Atrial Septal Defects

The GORE CARDIOFORM Septal Occluder has been approved by the FDA to treat ostium secundum atrial septal defects (ASD) via percutaneous closure procedures. In a clinical study of the device in 125 patients with ASD, ranging in age from 2 to 84, all who successfully received the implant maintained the closure when evaluated six months later.

The GO (Read more...)

Full Story →